-transparent.png){kind=logo}
The cAMP-dependent protein kinase-induced effects on phosphorylase and glycogen synthase activities and glucose production were studied in hepatocytes isolated from fed rats in the presence of the diastereomers of adenosine cyclic 3',5'-phosphorothioate, (Sp)-cAMPS and (Rp)-cAMPS. Incubation of hepatocytes with (Sp)-cAMPS or glucagon, both of which lead to cAMP-dependent protein kinase activation, resulted in a concentration-dependent increase in glycogen phosphorylase activity and a decrease in glycogen synthase activity. Incubation of hepatocytes with the cAMP-dependent protein kinase antagonist, (Rp)-cAMPS, in the absence of an agonist, had no significant effect on phosphorylase or glycogen synthase activities. Incubation of hepatocytes with a half-maximally inhibitory concentration of (Rp)-cAMPS shifted the agonist-induced activation curves for phosphorylase and the agonist-induced inhibition curves for glycogen synthase to 5-fold higher concentrations for both (Sp)-cAMPS and glucagon. Phosphorylase activity was very sensitive to the rapid, concentration-dependent inhibition by (Rp)-cAMPS of agonist-induced activation of cAMP-dependent protein kinase. The effects on phosphorylase activity were observable in 30 s and were concentration-dependent with half-maximal inhibition at 10 microM, similar to that observed for cAMP-dependent protein kinase. In contrast, glycogen synthase activity was less sensitive to (Rp)-cAMPS inhibition of agonist-induced activation of cAMP-dependent protein kinase. The effects on glycogen synthase activity lagged behind those on phosphorylase activity and the concentration dependence did not parallel the cAMP-dependent protein kinase effect, but was shifted to higher concentrations of (Rp)-cAMPS with half-maximal inhibition at 60 microM. Glucose (10 to 40 mM) increased the sensitivity of glycogen synthase to (Rp)-cAMPS inhibition of cAMP-dependent protein kinase over a narrow range of agonist concentration, but had no significant effect throughout most of the agonist-induced activation range. Thus, the diastereomers, (Sp)- and (Rp)-cAMPS, influence glycogen metabolism and the glycogenolytic enzymes through their modulation of cAMP-dependent protein kinase levels.
J D Rothermel, and
N L Perillo, and
J S Marks, and
L H Botelho
January 1985,
Journal of cyclic nucleotide and protein phosphorylation research,
J D Rothermel, and
N L Perillo, and
J S Marks, and
L H Botelho
April 1988,
The Journal of biological chemistry,
J D Rothermel, and
N L Perillo, and
J S Marks, and
L H Botelho
June 2004,
Biochemistry,
J D Rothermel, and
N L Perillo, and
J S Marks, and
L H Botelho
July 1986,
The Biochemical journal,
J D Rothermel, and
N L Perillo, and
J S Marks, and
L H Botelho
June 1980,
European journal of biochemistry,
J D Rothermel, and
N L Perillo, and
J S Marks, and
L H Botelho
September 1976,
European journal of biochemistry,
J D Rothermel, and
N L Perillo, and
J S Marks, and
L H Botelho
March 1993,
FEBS letters,
J D Rothermel, and
N L Perillo, and
J S Marks, and
L H Botelho
October 1982,
European journal of biochemistry,
J D Rothermel, and
N L Perillo, and
J S Marks, and
L H Botelho
December 1973,
The Journal of biological chemistry,
J D Rothermel, and
N L Perillo, and
J S Marks, and
L H Botelho
November 1992,
Molecular endocrinology (Baltimore, Md.),
